# OnCo record kirsten-fischer (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/kirsten-fischer/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "kirsten-fischer" ;
  schema:name "Kirsten Fischer"@en ;
  schema:description "Led CLL14, which established one year of venetoclax plus obinutuzumab as a fixed-duration, chemotherapy-free CLL treatment."@en ;
  schema:url <https://onco.cc/people/kirsten-fischer/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Fischer%20K%5BAuthor%5D%20CLL14%20venetoclax> ;
  onco:tag "cll", "venetoclax", "fixed-duration" ;
  schema:jobTitle "Senior Physician and Study Coordinator, German CLL Study Group, University Hospital Cologne" ;
  onco:cancers <https://onco.cc/cancers/cll/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:targets <https://onco.cc/targets/bcl2/>, <https://onco.cc/targets/cd20/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/> ;
  onco:institutions <https://onco.cc/institutions/uniklinik-koeln/> ;
  onco:trials <https://onco.cc/trials/cll14/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-cll14-venetoclax-obinutuzumab-nejm-2019/> ;
  schema:affiliation <https://onco.cc/institutions/uniklinik-koeln/> .